Itraconazole,
Orungal,
R 51211,
R-51211,
R51211,
Sporanox,
itraconazole,
84625-61-6,
Oriconazole,
Sporanox,
Itraconazolum [Latin],
ITRAZOLE,
R 51211,
Itraconazol,
MLS000863291,
Oriconazole, R51211, Sporanox,
R51211,
Itraconazol [Spanish],
SMR000058959,
C35H38Cl2N8O4,
R-51211,
BRN 6042047,
2049588-24-9,
4-(4-(4-(4-((2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-(sec-butyl)-1H-1,2,4-triazol-5(4H)-one,
Itraconazole Impurity E,
SR-01000003153,
252964-65-1,
Itraconzaole,
trans Itraconazole,
Itraconazole,(S),
NCGC00018268-03,
(+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one,
3H-1,2,4-Triazol-3-one, 4-(4-(4-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-2,4-dihydro-2-(1-methylpropyl)-,
4-(4-(4-(4-((2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-sec-butyl-1H-1,2,4-triazol-5(4H)-one,
Itraconazole [USAN:BAN:INN:JAN],
Itraconazole(Sporanox),
PubChem16053,
Opera_ID_902,
Itraconazole oral solution,
AC1L1GQ5,
SCHEMBL95627,
MLS000028582,
MLS000759472,
MLS001148245,
MLS001424065,
CHEMBL64391,
Itraconazole, >=98% (TLC),
SCHEMBL16984893,
CHEBI:94366,
CTK6C9122,
HMS2051K14,
HMS2090M20,
HMS2235M11,
HMS3370P13,
HMS3393K14,
HMS3713B16,
BCP28497,
KS-00000JQ3,
BDBM50011478,
DL-427,
MFCD00870168,
STL450986,
AKOS000280875,
AKOS022171690,
CCG-100876,
CCG-220567,
LS-1843,
NC00126,
NCGC00018268-02,
NCGC00089812-03,
AK133082,
CPD000058959,
SAM001246679,
AB0068822,
FT-0082511,
I0732,
ST24025102,
J10270,
M-9651,
AB00383031-14,
625I616,
I01-1043,
Itraconazole, Antibiotic for Culture Media Use Only,
J-015921,
Q-201261,
SR-01000003153-5,
SR-01000003153-6,
Itraconazole, European Pharmacopoeia (EP) Reference Standard,
Itraconazole, United States Pharmacopeia (USP) Reference Standard,
Itraconazole for system suitability, European Pharmacopoeia (EP) Reference Standard,
Itraconazole, Pharmaceutical Secondary Standard; Certified Reference Material,
(+/-)-4-[4-[4-[4-[[(2R,4S)-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one,
(+/-)-cis-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1h-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]-methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3h-1,2,4-triazol-3-one,
1-(butan-2-yl)-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one,
1-(Butan-2-yl)-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one,
2-(butan-2-yl)-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one,
2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one,
2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one,
2-sec-butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1h-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3h-1,2,4-triazol-3-one,
Triasporin,
Canditral,
Itrizole,
Traconal,
Orungal,
Itraconazolum,
Candistat,
Hyphanox,
Sporamelt,
Sporonox,
Itralek,
Sempera,
Sporal,
Itrac,
Spherazole CR,
Spherazole IR,
Butyl Itraconazole,
SUBA Itraconazole,
Itraconazole (Sporanox),
UNII-304NUG5GF4,
HSDB 7839,
CID3793,
DRG-0044,
Itraconazole [USAN:INN:BAN:JAN],
C35-H38-Cl2-N8-O4,
ACN-039957,
Itraconazole [USAN:USP:INN:BAN:JAN],
D017964,
(+/-)-1-[( R *)- sec -butyl]-4-[ p -[4-[ p -[[(2 R *,4 S *)-2-(2,4-dichlorophenyl)-2-(1 H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-(DELTA) 2 1,2,4-triazolin-5-one mixture with (+/-)-1-[( R *)- sec -butyl]-4-[ p -[4- [ p -[[(2 S *,4 R *)-2-(2,4-dichlorophenyl)-2-(1 H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl] phenyl]-(DELTA) 2 -1,2,4-triazolin-5-one,
3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-,
89848-21-5,
89848-51-1,